Curis Lifesciences
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Grey market premium
Unofficial and indicative — not a forecast
3 observations recorded — too few to plot a trend.
Day-wise premium · 3 observations
| Date | GMP | % | Sauda | Est. listing | Gain / lot |
|---|---|---|---|---|---|
| 14 Nov 2025 | ₹9 | +7.03% | ₹6,800 | ₹137 | ₹9,000 |
| 13 Nov 2025 | ₹9 | +7.03% | ₹6,800 | ₹137 | ₹9,000 |
| 12 Nov 2025 | ₹9 | +7.03% | ₹6,800 | ₹137 | ₹9,000 |
Gain per lot assumes the premium holds to listing and that the application is allotted — allotment in an oversubscribed issue is a lottery, so it is indicative, not expected. Sauda is the rate paid for a submitted application itself.
Issue details
- IPO date
- 07 Nov 2025 – 11 Nov 2025
- Listing date
- 14 Nov 2025
- Face value
- ₹10 per share
- Issue price
- ₹128 per share
- Lot size
- 1,000 shares
- Issue type
- Book Building issue
- Listing at
- NSE
- Total issue size
- ₹27.52 Cr
- Market cap at offer price
- ₹103 Cr
- Promoter holding
- 92.68% → 68.03% pre-issue → post-issue
- ISIN
- INE1BZN01016
- Registrar
- MUFG Intime India Pvt.Ltd.
- Lead managers
- Finaax Capital Advisors Private Limited
- Registered office
- PF-23, GIDC Sanand-II, Industrial Estate, Sanand, Gujarat
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| Anchor investor · within QIB | 6,09,000 | — | — |
| Market maker | 1,08,000 | — | — |
Application size
Minimum 1,000 shares per lot, in multiples, at ₹128
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 1,000 | ₹1,28,000 |
| S-HNI (min) | 2 | 2,000 | ₹2,56,000 |
| S-HNI (max) | 7 | 7,000 | ₹8,96,000 |
| B-HNI (min) | 8 | 8,000 | ₹10,24,000 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Anchor investors
Institutional allocation placed a day before the issue opens, carved out of the QIB portion and locked in after listing.
Valuation and performance
Valuation at offer price
₹128 per share
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 10.29 | 10.66 |
| P/E (×) | 12.44 | 12.01 |
| Price to book (×) | 12.64 | — |
| Market cap | — | ₹103 Cr |
Key performance indicators
Latest reported period
- Return on net worth
- 37.62%
- ROCE
- 27.83%
- Debt / equity
- 0.96
- PAT margin
- 12.43%
- EBITDA margin
- 19.41%
- NAV per share
- ₹27.34
- Price to book
- 12.64
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.